Seawater bacteria provides leads to fight melanoma

March 6, 2019, American Chemical Society
Seawater bacteria provides leads to fight melanoma
Credit: American Chemical Society

Malignant melanoma can be a particularly dangerous form of cancer, and more therapeutic options are needed. Now, researchers report in ACS Medicinal Chemistry Letters that a bacteria from seawater has inspired promising leads for an entirely new way to treat the disease.

In melanoma, form in melanocytes, the cells that color the skin. While new cases of most types of are declining, those of melanoma—the deadliest form of skin cancer—continue to climb, according to the U.S. Centers for Disease Control and Prevention. If melanoma metastasizes, or migrates to other locations in the body, prognosis is poor and treatment options are limited. New chemotherapy agents were recently approved that target melanomas with so-called "BRAF" mutations, but some of these tumors are already showing resistance to these therapies. William Fenical, James J. La Clair, Leticia Costa-Lotufo and colleagues decided the best solution would be to take aim at a completely different biochemical pathway in melanoma.

In 2014, the researchers discovered that seriniquinone, a natural product isolated from a rare marine bacteria, showed potent and selective activity against melanoma cells in a test tube. Even better, it was the first small molecule ever shown to target a particular protein involved in cancer proliferation. In their new work, the team identified the structural components of the natural product that were key to its activity, and then modified other parts of the molecule to make it more water soluble and easier to purify. Both these steps are necessary to make it more suitable as a drug. The researchers are now further refining these seriniquinone derivatives to optimize activity against .

Explore further: Researchers discover method to 'turn off' mutated melanoma

More information: Justin C. Hammons et al. Advance of Seriniquinone Analogues as Melanoma Agents, ACS Medicinal Chemistry Letters (2019). DOI: 10.1021/acsmedchemlett.8b00391

Related Stories

Researchers discover method to 'turn off' mutated melanoma

January 31, 2019

Melanoma is the deadliest form of skin cancer and notorious for its resistance to conventional chemotherapy. Approximately 25 percent of melanoma is driven by oncogenic mutations in the NRAS gene, making it a very attractive ...

A tiny RNA with a big role in melanoma

February 18, 2014

A Yale-led study has identified a key mechanism in the regulation of gene expression that promotes the proliferation of melanoma cells. The finding opens a possible avenue for development of treatments that target this mechanism. ...

Recommended for you

Study reveals properties of a Type Ib supernova in NGC 4080

March 25, 2019

A recent study conducted by astronomers has revealed important observational properties of a Type Ib supernova designated MASTER OT J120451.50+265946.6, which exploded in the galaxy NGC 4080. The research, presented in a ...

Catalyst advance removes pollutants at low temperatures

March 25, 2019

Researchers at Washington State University, University of New Mexico, Eindhoven University of Technology, and Pacific Northwest National Laboratory have developed a catalyst that can both withstand high temperatures and convert ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.